Nisa Investment Advisors LLC Increases Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Nisa Investment Advisors LLC increased its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 20,936.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 426,206 shares of the health services provider's stock after purchasing an additional 424,180 shares during the period. Nisa Investment Advisors LLC owned approximately 0.25% of Teladoc Health worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of TDOC. Versant Capital Management Inc grew its position in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Blue Trust Inc. raised its holdings in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after acquiring an additional 1,854 shares in the last quarter. Doheny Asset Management CA bought a new stake in shares of Teladoc Health during the 2nd quarter valued at $46,000. Benjamin F. Edwards & Company Inc. lifted its position in shares of Teladoc Health by 209.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider's stock valued at $49,000 after acquiring an additional 3,396 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. increased its position in shares of Teladoc Health by 194.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider's stock worth $67,000 after purchasing an additional 4,549 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on TDOC. TD Cowen dropped their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, October 31st. Barclays lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. Oppenheimer cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday. The Goldman Sachs Group started coverage on Teladoc Health in a research note on Friday, November 15th. They issued a "buy" rating and a $14.00 price target for the company. Finally, Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average price target of $12.08.

Insider Activity at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.95% of the stock is owned by insiders.

Teladoc Health Stock Down 0.8 %

TDOC traded down $0.08 during trading on Friday, hitting $10.06. 3,186,145 shares of the company's stock were exchanged, compared to its average volume of 3,507,271. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $21.74. The stock has a market cap of $1.73 billion, a P/E ratio of -1.74 and a beta of 1.01. The business's 50 day moving average is $10.01 and its two-hundred day moving average is $9.04. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.